Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.6, 2004-01, pp. : 397-401

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

By Garnock-Jones Karly P. Keating Gillian M.

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Adults with Attention Deficit Hyperactivity Disorder

By Simpson D. Plosker G.L.

Drugs, Vol. 64, Iss. 2, 2004-01 ,pp. : 205-222

Adis International

Access to resources Recommend Favorite

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

By Wilens T.E.

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2395-2411

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine Dimesylate: In Attention-Deficit Hyperactivity Disorder in Adults

By Weber Juliane Siddiqui M. Asif A.

CNS Drugs, Vol. 23, Iss. 5, 2009-05 ,pp. : 419-425

Adis International

Access to resources Recommend Favorite

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

By Stiefel Gary

Drug Safety, Vol. 33, Iss. 10, 2010-10 ,pp. : 821-842

Adis International

Access to resources Recommend Favorite